chr1-205065879-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_005076.5(CNTN2):c.1786G>A(p.Ala596Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000451 in 1,598,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A596V) has been classified as Uncertain significance.
Frequency
Consequence
NM_005076.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 4AN: 149916Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000918 AC: 23AN: 250422Hom.: 0 AF XY: 0.0000887 AC XY: 12AN XY: 135348
GnomAD4 exome AF: 0.0000470 AC: 68AN: 1448036Hom.: 0 Cov.: 34 AF XY: 0.0000527 AC XY: 38AN XY: 720758
GnomAD4 genome AF: 0.0000267 AC: 4AN: 150034Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73306
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1786G>A (p.A596T) alteration is located in exon 14 (coding exon 13) of the CNTN2 gene. This alteration results from a G to A substitution at nucleotide position 1786, causing the alanine (A) at amino acid position 596 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epilepsy, familial adult myoclonic, 5 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at